Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention

被引：19

作者：

Barzon L. ^{[1
]}

Giorgi C. ^{[2
]}

Buonaguro F.M. ^{[3
]}

Palù G. ^{[1
]}

机构：

[1] Department of Histology, Microbiology, and Medical Biotechnologies, University of Padova

[2] Department of Infectious, Parasitic, and Immunomediated Diseases, Istituto Superiore di Sanità, Roma

[3] Viral Oncology and AIDS Reference Centre, National Cancer Institute, Fondazione Pascale, Cappella Cangiani

来源：

Infectious Agents and Cancer | / 3卷 / 1期

关键词：

Cervical Cancer; Cervical Cancer Screening; Long Control Region; Conventional Cytology;

D O I：

10.1186/1750-9378-3-14

中图分类号：

学科分类号：

摘要：

Objective. To provide guidelines for health-care providers on strategies for cervical cancer prevention based on HPV testing and anti-HPV vaccination. Outcomes. Overall efficacy of different preventive strategies, assessing reduction in the incidence of invasive cervical cancer and precancerous lesions. Evidence. Medline and the Cochrane Database were searched for articles in English on subjects related to HPVs, HPV diagnosis, HPV anogenital lesions, cervical cancer, HPV testing, and HPV vaccines, in order to elaborate an up-dated document. Relevant Italian Government publications and position papers from appropriate health and family planning organizations were also reviewed. Values. The quality of the evidence and ranking of recommendations for practice were rated using criteria defined by SIV, which were adapted from the Canadian Task Force on Preventive Health Care. © 2008 Barzon et al; licensee BioMed Central Ltd.

引用

共 132 条

[1]

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses, 90, (2007)

[2]

Ferlay J., Bray F., Pisani P., Parkin D.M., GLOBOCAN 2002 cancer incidence. Mortality and prevalence worldwide, IARC CancerBase No. 5 Version 2.0, (2004)

[3]

Parkin D.M., Whelan S.L., Ferlay J., Teppo L., Editors B.T.D., Cancer Incidence in Five Continents, 3, (2002)

[4]

Arbyn M., Autier P., Ferlay J., Burden of cervical cancer in the 27 member states of the European Union: Estimates for 2004, Ann Oncol, 18, pp. 1425-1427, (2007)

[5]

Cervical cancer, E&p Anno 30 Gennaio-febbraio, SUPPL. 2, (2006)

[6]

Ries L.A.G., Eisner M.P., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., Mariotto A., Feuer E.J., Editors K.E.B., SEER Cancer Statistics Review, 1975-2002, (2005)

[7]

Sant M., Aareleid T., Berrino F., Bielska Lasota M., Carli P.M., Faivre J., Grosclaude P., Hedelin G., Matsuda T., Moller H., Moller T., Verdecchia A., Capocaccia R., Gatta G., Micheli A., Santaquilani M., Roazzi P., Group Working Eurocare L.D., EUROCARE-3: Survival of cancer patients diagnosed 1990-94 - results and commentary, Ann Oncol, 14, SUPPL. 5, pp. 61-118, (2003)

[8]

Gondos A., Chokunonga E., Brenner H., Parkin D.M., Sankila R., Borok M.Z., Chirenje Z.M., Nyakabau A.M., Bassett M.T., Cancer survival in southern African urban population, Int J Cancer, 112, pp. 860-864, (2004)

[9]

Zur Hausen H., Meinhof W., Scheiber W., Bornkamm G.W., Attempts to detect virus-specific DNA sequences in human tumors: I. Nucleic acid hybridization with complementary RNA of human wart virus, Int J Cancer, 13, pp. 650-656, (1974)

[10]

De Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., Zur Hausen H., Classification of papillomaviruses, Virology, 324, pp. 17-27, (2004)

← 1 2 3 4 5 6 7 8 9 10 →